Martingale Asset Management L P Black Diamond Therapeutics, Inc. Call Options Transaction History
Martingale Asset Management L P
- $4.02 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BDTX
# of Institutions
97Shares Held
41.4MCall Options Held
0Put Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.5MShares$40.5 Million0.02% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$21.6 Million0.73% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$17.1 Million0.91% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$12.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.73MShares$10.5 Million0.15% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $140M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...